Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

22%

2 trials in Phase 3/4

Results Transparency

50%

3 of 6 completed trials have results

Key Signals

1 recruiting3 with results

Enrollment Performance

Analytics

N/A

5(55.6%)

Phase 3

2(22.2%)

Phase 2

1(11.1%)

Phase 1

1(11.1%)

9Total

N/A(5)

Phase 3(2)

Phase 2(1)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT04235816Phase 3Active Not Recruiting

Improving Care Through Azithromycin Research for Infants in Africa

Role: collaborator

NCT05949190Not ApplicableActive Not Recruiting

Improving Cognition and Gestational Duration With Targeted Nutrition

Role: collaborator

NCT06869850Not ApplicableRecruiting

Milk Fat Globule Membrane-Enhanced RUTF for Children With Severe Acute Malnutrition

Role: collaborator

NCT06002438Not ApplicableCompleted

Eggs for Gut Health

Role: collaborator

NCT04334538Not ApplicableCompleted

Effect of an Alternative RUTF on Intestinal Permeability in Children With Severe Acute Malnutrition

Role: collaborator

NCT02509494Phase 3Completed

Staged Phase 3 Study to Assess the Safety and Immunogenicity of Ebola Candidate Vaccines Ad26.ZEBOV and MVA-BN-Filo

Role: collaborator

NCT02363322Phase 1Completed

Putative Investigational Therapeutics in the Treatment of Patients With Known Ebola Infection

Role: collaborator

NCT03146897Not ApplicableCompleted

Comparison of Four Different Supplementary Foods in the Treatment of Moderate Acute Malnutrition

Role: collaborator

NCT02378753Phase 2Completed

STRIVE (Sierra Leone Trial to Introduce a Vaccine Against Ebola)

Role: collaborator

All 9 trials loaded